TiMi Robotics was founded in January 2015, had in September 2016 had obtained 10 million yuan angel round financing jointly invested by GuoKeJiaHe and Shanghai ChuangTu, and obtained 40 million yuan A round financing in May 2017, led by IDG, followed by GuoKeJiaHe, KeWuShi and ChuangTu Fund. Completed RMB 200 million Series B financing in May 2018, led by Jinpu Investment and followed by CDH Investment as well as RMB 60 million Series B+ financing in October 2018, invested by Pudong Science and Technology, Zhangjiang Torch Venture Capital, Zhangjiang Haocheng, Shanghai Zhangjiang Science and Technology Investment, and Creative Apprenticeship Investment.
According to the company's official website, Shanghai TiMi Robotics Technology Co., Ltd. is the first high-tech enterprise in China to provide intelligent robotics solutions for intelligent medical scenarios, using robots as a carrier to build a medical informationization platform system covering the fields of operating room drugs, consumables, and instrument management, ward nursing and hospital-inspection management, which will improve the decision-making and supervisory efficiency of hospitals and reduce the cost of medical care, provide a better service to patients to improve the medical experience, and for healthcare workers to reduce occupational injuries. At present, TiMi's various system solutions have been applied to more than 130 large-scale tertiary hospitals in China, providing solutions for more than 10 scenarios of medical care. As a leader in the medical robotics industry, TiMi is continuously helping the construction and development of intelligent hospitals through the deep integration of robotics technology and medical business.